Additionally, we found that the miR-34a inhibitor attenuated the inhibitory effects of DNMT3B knockdown on EMT, indicating that DNMT3B silencing suppresses EMT by upregulating miR-34a in bladder cancer. This evidence concerns the gene DNMT3B and urinary bladder carcinoma.